aTyr Pharma
LIFE
$1.90
Share price
2.70%
Change (1 day)
-14.03%
Change (1 year)
Categories
Earnings for aTyr Pharma (LIFE)
Earnings in 2023 (TTM): -$54.92 M
According to aTyr Pharma's latest financial reports the company's current earnings (TTM) are -$58.77 M. In 2022 the company made an earning of -$46.41 M a decrease over its 2021 earnings that were of -$34.02 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for aTyr Pharma from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$54.92 M | 18.35% |
| 2022 | -$46.41 M | 36.42% |
| 2021 | -$34.02 M | 113.78% |
| 2020 | -$15.92 M | -30.76% |
| 2019 | -$22.98 M | -29.99% |
| 2018 | -$32.82 M | -30.38% |
| 2017 | -$47.15 M | -18.63% |
| 2016 | -$57.94 M | 21.68% |
| 2015 | -$47.62 M | 102.47% |
| 2014 | -$23.52 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | $4.81 B | -8,285.58% | 🇺🇸 USA |
 Veracyte VCYT | -$70.43 M | 19.83% | 🇺🇸 USA |